Case Report
Published on 25 Apr 2023
Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor: A case report
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1124276
- 1,928 views
- 4 citations
Type at least 3 characters
344 articles
Articles
Case Report
Published on 19 Apr 2023
Case report: Early acute myocarditis after radiation therapy for breast cancer: A case presentation and review of literature
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1020082
- 1,805 views
- 1 citation
Original Research
Published on 06 Apr 2023
Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1093383
- 2,922 views
- 5 citations
Original Research
Published on 29 Mar 2023
Early detection and serial monitoring during chemotherapy-radiation therapy: Using T1 and T2 mapping cardiac magnetic resonance imaging
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1085737
- 1,351 views
- 2 citations
Review
Published on 20 Mar 2023
Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1152436
- 2,866 views
- 1 citation
Case Report
Published on 14 Mar 2023
Case report: Diagnosis, management and evolution of a bulky and invasive cardiac mass complicated by complete atrioventricular block
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1135233
- 1,184 views
Review
Published on 10 Mar 2023
Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1080299
- 2,873 views
Correction
Published on 09 Mar 2023
Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1169176
- 956 views
- 1 citation
Original Research
Published on 09 Mar 2023
Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.884174
- 2,756 views
- 5 citations
Review
Published on 07 Mar 2023
Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1089916
- 3,377 views
- 3 citations
Original Research
Published on 03 Mar 2023
Association between thyroid cancer and cardiovascular disease: A meta-analysis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1075844
- 3,552 views
- 2 citations
Case Report
Published on 01 Mar 2023
Surgical resection of a giant cardiac angiosarcoma and reconstruction of involved right heart structures: A case report
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1115962
- 1,409 views
General Commentary
Published on 27 Feb 2023
Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.982028
- 1,634 views
- 1 citation
Mini Review
Published on 21 Feb 2023
Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1090103
- 3,514 views
- 9 citations
Review
Published on 17 Feb 2023
Galectin functions in cancer-associated inflammation and thrombosis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1052959
- 5,971 views
- 10 citations
Case Report
Published on 15 Feb 2023
A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.984572
- 2,368 views
- 4 citations